Coronary and peripheral artery atherosclerosis: what choice for antiplatelet therapy

J Cardiovasc Med (Hagerstown). 2018 Feb:19 Suppl 1:e72-e74. doi: 10.2459/JCM.0000000000000557.
No abstract available

Publication types

  • Review

MeSH terms

  • Clinical Decision-Making
  • Coronary Artery Disease / diagnosis
  • Coronary Artery Disease / drug therapy*
  • Coronary Artery Disease / epidemiology
  • Coronary Artery Disease / physiopathology
  • Hemorrhage / chemically induced
  • Humans
  • Patient Selection
  • Peripheral Arterial Disease / diagnosis
  • Peripheral Arterial Disease / drug therapy*
  • Peripheral Arterial Disease / epidemiology
  • Peripheral Arterial Disease / physiopathology
  • Platelet Aggregation Inhibitors / administration & dosage*
  • Platelet Aggregation Inhibitors / adverse effects
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome

Substances

  • Platelet Aggregation Inhibitors